Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
European equities traded in the US as American depositary receipts were moving sharply lower late Friday morning, falling 1.5% to 1,333.73 on the S&P Europe Select ADR Index, which is down about 2.5% for the week.
From continental Europe, the gainers were led by 3D printer company Materialise and biotech firm BioNTech (BNTX), which rose 7.5% and 5.8% respectively. They were followed by biopharmaceutical companies Grifols and Cellectis (CLLS), which were up 1.1% each.
The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and semiconductor company Sequans Communications , which dropped 6.6% and 4.3% respectively. They were followed by conglomerate Philips and biopharmaceutical company DBV Technologies , which were down 3.6% and 1.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics and hospitality company InterContinental Hotels Group , which advanced 3.6% and 2.1% respectively. They were followed by cruise line operator Carnival and biopharmaceutical company Mereo BioPharma Group , which increased 1.7% and 0.6% respectively.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics and biopharmaceutical company TC Biopharm , which dropped 6.1% and 6% respectively. They were followed by insurance company Prudential and mining company BHP Group , which lost 5% and 4.9% respectively.
European equities traded in the US as American depositary receipts were higher Thursday, rising 1.11% to 1,352.23 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet browser company Opera and Philips , which rose 5.2% and 3.9% respectively. They were followed by SAP , which added 3.1%.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies and semiconductor company Sequans Communications , which fell 3.7% and 2.1% respectively. They were followed by 3D printer company Materialise and medical device maker EDAP TMS , which were down 1.5% and 1.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics and biotech firm Autolus Therapeutics , which climbed 6.7% and 6.2% respectively. They were followed by software firm Endava , which increased 4.9%.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics and Adaptimmune Therapeutics , which dropped 4.2% and 1.6% respectively. They were followed by cruise line operator Carnival and biopharmaceutical company Verona Pharma , which were off 0.7% and 0.6% respectively.
European equities traded in the US as American depositary receipts started the week tracking higher late Monday morning, rising 0.49% to 1,366.51 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies and internet advertising firm Criteo , which rose 4.4% and 4.8% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria and tech conglomerate Philips , which increased 3% and 2.7% respectively.
The decliners from continental Europe were led by medical device maker EDAP TMS and pharmaceutical company Novo Nordisk , which fell 5.1% and 1.6% respectively. They were followed by 3D printer company Materialise and biotech firm BioNTech , which were down 1.6% and 1.4% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics and Bicycle Therapeutics , which were up 5.9% and 4.2% respectively. They were followed by biopharmaceutical companies Amarin and NuCana , which rose 2.8% and 2.6% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics and Biodexa Pharmaceuticals B, which lost 5.3% and 1.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group and biotech firm Trinity Biotech 2.4% and 2.3% respectively.
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
Also Read:
Photo via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.